Central Bank & Trust CO Abb Vie Inc. Transaction History

Central Bank & Trust CO

$708 Million
Q3 2024

A detailed history of Central Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Central Bank & Trust CO holds 3,346 shares of ABBV stock, worth $595,621. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,346

Previous 3,346 -0.0%

Holding current value

$595,621

Previous $573,000 15.18%

% of portfolio

0.09%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $10,867 - $12,382	-68 Reduced 1.99%	3,346 $609,000
Q4 2023 Jan 09, 2024	BUY	$137.6 - $154.97 $232,819 - $262,209	1,692 Added 98.26%	3,414 $529,000
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $14,311 - $17,809	108 Added 6.69%	1,722 $232,000
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $61,025 - $70,279	-422 Reduced 20.73%	1,614 $257,000
Q4 2022 Jan 18, 2023	SELL	$138.31 - $165.87 $13,969 - $16,752	-101 Reduced 4.73%	2,036 $0
Q3 2022 Oct 20, 2022	BUY	$134.21 - $153.93 $38,518 - $44,177	287 Added 15.51%	2,137 $287,000
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $14,587 - $18,545	106 Added 6.08%	1,850 $283,000
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $27,847 - $34,551	211 Added 13.76%	1,744 $283,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $53,715 - $67,965	500 Added 48.4%	1,533 $208,000
Q4 2020 Jan 12, 2021	BUY	$80.49 - $108.67 $8,048 - $10,867	100 Added 10.72%	1,033 $111,000
Q3 2020 Oct 08, 2020	BUY	$85.91 - $100.83 $17,182 - $20,166	200 Added 27.29%	933 $82,000
Q2 2020 Jul 15, 2020	SELL	$73.37 - $98.18 $70,141 - $93,860	-956 Reduced 56.6%	733 $72,000
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $61,662 - $93,487	956 Added 130.42%	1,689 $123,000
Q1 2020 Apr 14, 2020	SELL	$64.5 - $97.79 $32,250 - $48,895	-500 Reduced 40.55%	733 $56,000
Q4 2019 Jan 13, 2020	SELL	$72.13 - $90.25 $1,658 - $2,075	-23 Reduced 1.83%	1,233 $109,000
Q3 2019 Oct 23, 2019	SELL	$62.98 - $75.72 $27,270 - $32,786	-433 Reduced 25.64%	1,256 $95,000
Q2 2019 Jul 16, 2019	SELL	$65.7 - $83.98 $291,970 - $373,207	-4,444 Reduced 72.46%	1,689 $123,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $168,010 - $197,740	-2,178 Reduced 26.21%	6,133 $494,000
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $14,557 - $17,953	187 Added 2.3%	8,311 $766,000
Q3 2018 Nov 23, 2018	BUY	$88.91 - $98.84 $32,541 - $36,175	366 Added 4.72%	8,124 $768,000
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $12,479 - $14,765	-139 Reduced 1.76%	7,758 $719,000
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $62,106 - $83,166	675 Added 9.35%	7,897 $747,000
Q4 2017 Jan 16, 2018	BUY	$89.56 - $98.21 $2,776 - $3,044	31 Added 0.43%	7,222 $698,000
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $502,291 - $641,581	7,191	7,191 $639,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Account

Central Bank & Trust CO Abb Vie Inc. Transaction History